Results 91 to 100 of about 4,584 (134)

A Synergistic Dual-Antibody Cocktail Targeting α-Toxin Protects Against Invasive <i>Staphylococcus aureus</i> Infection by Neutralizing Virulence and Enhancing Host Defense. [PDF]

MedComm (2020)
Zhao L, Song Z, Fan H, Wang L, Yang Y, Jing H, Xia X, Wang Y, Feng L, Wang S, Chen Z, Gou Q, Yuan Y, Zhang J, Zou Q, Zeng H.   +15 more
europepmc   +1 more source

Anti-CD38 monoclonal antibodies in multiple myeloma and beyond: immunotherapeutic mechanisms, evidence maturity, and clinical positioning. [PDF]

Front Immunol
Yu L, Li C, Guo D, Cui S.
europepmc   +1 more source

Human Antibody Isotypes, Subclasses, Allotypes and Fc Biology: Clinical Implications in Infectious Diseases, Autoimmunity, and Cancer. [PDF]

Pharmaceuticals (Basel)
Gautam S, Singh S, Thakkar V, Joshi D, Kumar S.   +4 more
europepmc   +1 more source

Development and non-clinical characterization of Procizumab (invobenitug): a humanized antibody neutralizing circulating DPP3. [PDF]

MAbs
Genest M, Van Lier D, Uba TI, Schroeter A, Picod A, Nordin H, Assad N, Marguerit G, Nguyen A, Bergmann A, Pickkers P, Mebazaa A, Santos K, Azibani F.   +13 more
europepmc   +1 more source

Research advances on CD47 in digestive system cancers: from molecular mechanisms to clinical translation. [PDF]

Mol Med
Sun H, Wei C, Long J, Liu X, Li Q, Cao B.   +5 more
europepmc   +1 more source

Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway. [PDF]

J Immunother Cancer
Beers C, Ilaria RL, Luke JJ.
europepmc   +1 more source

Long-term cross-variant Fc-mediated immune responses against SARS-CoV-2 induced by a heterologous adenoviral/inactivated virus prime-boost vaccination strategy. [PDF]

NPJ Vaccines
Kim D, Lee JH, Lee J, Park JY, Shin Y, Kim SJ, Cheon B, Lee S, Cho E, Kim DR, McNamara RP, Yun CH, Siribie M, Aziz AB, Tadesse BT, Marks F, Jo SK, Jeon HJ, Rakotozandrindrainy R, Jani IV, Yang JS, Shim BS, Song M.   +22 more
europepmc   +1 more source

Co-phagocytosis by bispecific antibodies, a novel strategy for targeted degradation of soluble factors in the tumor microenvironment. [PDF]

Cancer Lett
Fan Z.
europepmc   +1 more source

Protocol for robust gene knockout and reliable validation in human cell lines using quad-guide RNA vectors. [PDF]

STAR Protoc
Tobin M, Dai J, Chan LC, Guo W.
europepmc   +1 more source

Myeloid cell-mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference. [PDF]

Blood Neoplasia
Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.   +29 more
europepmc   +1 more source